Status:

RECRUITING

Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living With Diabetes Using Continuous Glucose Monitoring ( GAP OUEST )

Lead Sponsor:

Nantes University Hospital

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn about the variability of HGI (Hemoglobin Glycation Index) over time in patients living with diabetes using a continuous glucose monitoring.

Eligibility Criteria

Inclusion

  • Major (adult subject over 18), with no upper age limit
  • Enrolled in a social security scheme or beneficiary of such a scheme
  • Agreement to participate (informed, written consent)
  • Established diabetes (regardless the type of diabetes), known for at least 6 months at inclusion
  • Regular user of a glucose monitoring system for at least 3 months.
  • Non inclusion Criteria:
  • Known hemoglobinopathy
  • Inadequate use of the flash glucose monitoring system with a capture rate of less than 70% of interstitial glucose measurements, during the 3 months preceding the inclusion visit.
  • Stage 5 renal insufficiency (CKD-EPI less than 15 mL/min/1.73 m2)
  • Pregnant or breast-feeding
  • Major under guardianship, curatorship or safeguard of justice
  • Any situation assessed by the investigator as potentially prejudicial to the participant's health as a result of participation in the study

Exclusion

  • Treatment with corticosteroids in the 3 months preceding the visit
  • Unusual acute situation (infection, very unusual physical activity, etc.) deemed significant by the investigator
  • Pregnancy started

Key Trial Info

Start Date :

June 24 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2028

Estimated Enrollment :

750 Patients enrolled

Trial Details

Trial ID

NCT06185491

Start Date

June 24 2024

End Date

September 1 2028

Last Update

November 18 2025

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

CHU d'Angers

Angers, France, 49100

2

CHU de Brest

Brest, France, 29200

3

CHU de Caen

Caen, France, 14033

4

CH de La Rochelle

La Rochelle, France, 17019

Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living With Diabetes Using Continuous Glucose Monitoring ( GAP OUEST ) | DecenTrialz